Abbott Vascular

3200 Lakeside Dr.

Santa Clara, CA 95054

USA

Phone:

(408) 845-3000

www.abbottvascular.com

Product Categories:

Embolic Protection Devices, Stents, Stents Drug Eluting, Vascular Closure Devices, Stents Carotid, Stents Peripheral, Stents Bare Metal

Related Content

The bioresorbable Cordis Mynx Grip vascular closure device seals arteriotomies without use of permanent hardware.

The bioresorbable Cordis MynxGrip vascular closure device seals arteriotomies without use of permanent hardware.

Feature | Vascular Closure Devices | January 22, 2018 | Dave Fornell

Advances and Trends in Vascular Closure Devices

While manual compression remains the gold standard for hemostasis of catheterization vascular access site arteriotomi

Technology | EP Mapping and Imaging Systems | January 19, 2018

Abbott Announces European Launch of Advisor HD Grid Mapping Catheter, Sensor Enabled

Abbott last week announced CE Mark approval for the company's new Advisor HD Grid Mapping Catheter, Sensor Enabled, a...

The Abbott Absorb Bioresorbable Vascular Scaffold (BVS) bioabsorbable stent.

The Abbott Absorb Bioresorbable Vascular Scaffold (BVS).

Feature | Stents Drug Eluting | January 17, 2018 | Dave Fornell

Current State of Bioresorbable Stent Technology

There was no shortage of interest in bioresorbable stent technologies at the many sessions offered on this topic or b

Technology | Cardiac Resynchronization Therapy Devices (CRT) | January 03, 2018

Abbott Announces MR-Conditional Labeling for Quadra Assura CRT-D and Fortify Assura ICD

Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...

Technology | Stents Drug Eluting | November 09, 2017

Abbott Gains European Approval for Xience Sierra Stent

November 9, 2017 — Abbott received European CE mark for Xience Sierra, the newest generation of the company's Xience

The Abbott/St. Jude Confirm RX implantable cardiac monitor (ICM) is the first ICM that is compatible with patients' smartphones to eliminate the need for a bedside base unit monitor to transfer data to physicians. Its FDA clearance was in October 2017.

The Abbott/St. Jude Confirm RX implantable cardiac monitor (ICM) is the first ICM that is compatible with patients' smartphones to eliminate the need for a bedside base unit monitor to transfer data to physicians. Its FDA clearance was the No. 1 most popular article on DAIC in October.

Feature | November 03, 2017 | Dave Fornell

November 3, 2017 — Here is the list of the most popular articles and videos on the Diagnostic and Interventional Card

News | Stents Bioresorbable | October 31, 2017

Thirty-Day ABSORB IV Results Demonstrate Improvements Still Needed in Bioresorbable Stents

Thirty-day results from ABSORB IV, the largest randomized everolimus-eluting bioresorbable vascular scaffold (BVS)...

News | Stents Bioresorbable | October 31, 2017

FDA Investigating Increased Major Adverse Cardiac Event Rates of Absorb Bioresorbable Stent

October 31, 2017 — The U.S.

Abbott SJM St. Jude Confirm RX implantable cardiac monitor (ICM).

The Abbott Confirm RX implantable cardiac monitor (ICM) is smaller than a computer thumb-drive and in implanted in a simple in-office procedure just under the skin.

Technology | Implantable Cardiac Monitor (ICM) | October 23, 2017

First Smartphone Compatible Insertable Cardiac Monitor Cleared by FDA

October 23, 2017 – The U.S.